BIOMAT Database Logo BIOMAT Database Logo

Sex hormones and sex hormone-binding globulin in males with chronic viral hepatitis during recombinant interferon-alpha 2b therapy. 1993

T Barreca, and A Picciotto, and R Franceschini, and G Varagona, and A Garibaldi, and F Valle, and A Cataldi, and S D'Agostino, and E Rolandi
Department of Internal Medicine, University of Genoa, Italy.

The effect of long-term treatment with recombinant interferon-alpha 2b (IFN-alpha 2b) on luteinizing hormone (LH), testosterone, free testosterone, and sex hormone-binding globulin (SHBG) was evaluated in 7 male patients suffering from chronic viral hepatitis. The drug was given three times a week for 6 months in a single standard dose of 3 x 10(6) units. Hormone evaluations were performed in basal conditions and every 2 months for 12 months. Serum testosterone values decreased after IFN treatment, reaching the lowest levels at the 6th month. However, testosterone values did not fall below the normal range. Serum SHBG concentrations, which were above the normal range in basal conditions, also decreased after IFN. Serum-free testosterone and LH concentrations did not change during IFN therapy. IFN-alpha 2b at the dose and schedule employed was not responsible for any measurable imbalance in male sex hormones.

UI MeSH Term Description Entries
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077190 Interferon alpha-2 Alpha interferon encoded by the human IFNA2 gene. Recombinant forms are used in the treatment of CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; KAPOSI SARCOMA; MELANOMA; and HAIRY CELL LEUKEMIA. IFN-alpha 2,IFN-alpha-2,IFNalpha-2b, Recombinant,Interferon alfa-2a,Interferon alfa-2b,Interferon alpha-2b, Recombinant,Interferon alpha-A,Interferon-alpha 2,Intron A (Interferon),LeIF A,Reaferon,Recombinant Interferon alpha-2a,Recombinant Interferon alpha-2b,Ro 22-8181,Roferon-A,Sch-30500,Viferon,IFNalpha 2b, Recombinant,Interferon alfa 2a,Interferon alfa 2b,Interferon alpha 2,Interferon alpha 2b, Recombinant,Interferon alpha A,Interferon alpha-2a, Recombinant,Recombinant IFNalpha-2b,Recombinant Interferon alpha 2a,Recombinant Interferon alpha 2b,Ro 22 8181,Ro 228181,Roferon A,RoferonA,Sch 30500,Sch30500
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

T Barreca, and A Picciotto, and R Franceschini, and G Varagona, and A Garibaldi, and F Valle, and A Cataldi, and S D'Agostino, and E Rolandi
[Therapy of chronic viral hepatitis with recombinant interferon-alpha].
January 1992, Acta medica Austriaca,
T Barreca, and A Picciotto, and R Franceschini, and G Varagona, and A Garibaldi, and F Valle, and A Cataldi, and S D'Agostino, and E Rolandi
Long-term interferon-alpha therapy does not affect sex hormones in males with chronic hepatitis C.
September 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,
T Barreca, and A Picciotto, and R Franceschini, and G Varagona, and A Garibaldi, and F Valle, and A Cataldi, and S D'Agostino, and E Rolandi
Sex steroids and sex-hormone binding globulin in males with chronic alcoholism.
October 1978, European journal of clinical investigation,
T Barreca, and A Picciotto, and R Franceschini, and G Varagona, and A Garibaldi, and F Valle, and A Cataldi, and S D'Agostino, and E Rolandi
Treatment of chronic hepatitis C with recombinant interferon alpha 2b.
October 1992, Journal of chemotherapy (Florence, Italy),
T Barreca, and A Picciotto, and R Franceschini, and G Varagona, and A Garibaldi, and F Valle, and A Cataldi, and S D'Agostino, and E Rolandi
Interferon alpha-2b therapy in chronic hepatitis delta.
March 2014, Hepatitis monthly,
T Barreca, and A Picciotto, and R Franceschini, and G Varagona, and A Garibaldi, and F Valle, and A Cataldi, and S D'Agostino, and E Rolandi
[Thyroid dysfunctions in children with chronic hepatitis C during interferon alpha-2b therapy].
January 2011, Przeglad lekarski,
T Barreca, and A Picciotto, and R Franceschini, and G Varagona, and A Garibaldi, and F Valle, and A Cataldi, and S D'Agostino, and E Rolandi
Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children.
January 1991, Progress in clinical and biological research,
T Barreca, and A Picciotto, and R Franceschini, and G Varagona, and A Garibaldi, and F Valle, and A Cataldi, and S D'Agostino, and E Rolandi
The interferon-alpha 2b gene in Japanese patients with chronic viral hepatitis who developed antibodies after treatment with recombinant interferon-alpha 2a.
January 1992, Journal of gastroenterology and hepatology,
T Barreca, and A Picciotto, and R Franceschini, and G Varagona, and A Garibaldi, and F Valle, and A Cataldi, and S D'Agostino, and E Rolandi
Sex hormones and sex hormone binding globulin in males with compensated and decompensated cirrhosis of the liver.
March 1989, Acta endocrinologica,
T Barreca, and A Picciotto, and R Franceschini, and G Varagona, and A Garibaldi, and F Valle, and A Cataldi, and S D'Agostino, and E Rolandi
Are corticosteroid-binding globulin and sex hormone-binding globulin hormones?
January 1988, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!